论文部分内容阅读
随着化疗方案的不断改进,儿童白血病的治疗效果已经有了令人鼓舞的提高,儿童急性淋巴细胞白血病(ALL)总体存活率已经达到80%左右,低危患儿的长期治愈率有望达到90%以上[1],但还是有相当数量的白血病病例难免复发死亡,尤其是急性髓系白血病(AML)的疗效远不如ALL,儿童AML的长期无
With the continuous improvement of chemotherapy regimens, the therapeutic effect of childhood leukemia has been greatly improved. The overall survival rate of childhood acute lymphoblastic leukemia (ALL) has reached about 80%, and the long-term cure rate of children with low risk is expected to reach 90 % [1], but there are still a considerable number of leukemia patients inevitably relapse death, especially acute myeloid leukemia (AML) is far less effective than ALL, childhood AML long-term no